| Literature DB >> 21826133 |
Kiran Singh1, Parvesh Puri, Yogender Kumar, Chetan Sharma, Kamal Rai Aneja.
Abstract
The Schiff bases HL(1-3) have been prepared by the reaction of 5-bromothiophene-2-carboxaldehyde with 4-amino-5-mercapto-3-methyl/propyl/isopropyl-s-triazole, respectively. Organosilicon(IV) and organotin(IV) complexes of formulae (CH(3))(2)MCl(L(1-3)), (CH(3))(2)M(L(1-3))(2) were synthesized from the reaction of (CH(3))(2)MCl(2) and the Schiff bases in 1 : 1 and 1 : 2 molar ratio, where M = Si and Sn. The synthesized Schiff bases and their metal complexes have been characterized with the aid of various physicochemical techniques like elemental analyses, molar conductance, UV, IR, (1)H, (13)C, (29)Si, and (119)Sn NMR spectroscopy. Based on these studies, the trigonal bipyramidal and octahedral geometries have been proposed for these complexes. The ligands and their metal complexes have been screened in vitro against some bacteria and fungi.Entities:
Year: 2011 PMID: 21826133 PMCID: PMC3150780 DOI: 10.1155/2011/654250
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Figure 1Structure of Schiff bases, where R = –CH3, HL1 = 4-(5-Bromothiophen-2-carboxylidene amino)-3-methyl-5-mercapto-s-triazole (BTMMT); R = –CH2–CH2–CH3, HL2 = 4-(5-Bromothiophen-2-carboxylidene amino)-5-mercapto-3-propyl-s-triazole (BTMPT); R = –CH(CH3)2, HL3 = 4-(5-Bromothiophen-2-carboxylidene amino)-3-isopropyl-5-mercapto-s-triazole (BTIMT).
Physical characteristics and analytical data of ligands and their metal complexes.
| Compound | Empirical formulae | Color | Decomposition Temp. (°C) | Molar conductance (Ω−1 cm2 mol−1) | Found (Calc.)% | ||||
|---|---|---|---|---|---|---|---|---|---|
| C | H | N | S | Si/Sn | |||||
| HL1(BTMMT) | C8H7BrN4S2 | Light Brown | 182 | — | 31.02 (31.69) | 2.43 (2.33) | 18.64 (18.48) | 21.21 (21.15) | — |
| Me2SiCl(L1) | C10H12BrClN4S2Si | Brown | 176 | 15.46 | 30.04 (29.44) | 3.21 (3.05) | 14.43 (14.24) | 16.12 (16.20) | 7.12 (7.10) |
| Me2Si(L1)2 | C18H18Br2N8S4Si | Light Yellow | 220 | 11.24 | 32.21 (32.63) | 2.87 (2.74) | 16.78 (16.91) | 19.32 (19.36) | 4.25 (4.24) |
| Me2SnCl(L1) | C10H12BrClN4S2Sn | Yellow | 222 | 14.82 | 24.98 (24.69) | 2.65 (2.49) | 11.44 (11.52) | 13.19 (13.18) | 24.35 (24.40) |
| Me2Sn(L1)2 | C18H18Br2N8S4Sn | Light Yellow | 238 | 10.78 | 28.64 (28.70) | 2.44 (2.41) | 14.34 (14.88) | 17.06 (17.03) | 15.74 (15.76) |
| HL2(BTMPT) | C10H11BrN4S2 | Dark Brown | 178 | — | 36.84 (36.26) | 3.66 (3.35) | 16.79 (16.91) | 19.42 (19.36) | — |
| Me2SiCl(L2) | C12H16BrClN4S2Si | Brown | 172 | 15.98 | 34.42 (34.00) | 3.54 (3.80) | 13.42 (13.22) | 15.21 (15.13) | 6.67 (6.63) |
| Me2Si(L2)2 | C22H26Br2N8S4Si | White | 234 | 11.43 | 36.21 (36.77) | 3.55 (3.65) | 15.61 (15.59) | 17.57 (17.85) | 3.89 (3.91) |
| Me2SnCl(L2) | C12H16BrClN4S2Sn | White | 224 | 14.52 | 28.76 (28.01) | 3.24 (3.13) | 10.02 (10.08) | 12.51 (12.47) | 23.10 (23.07) |
| Me2Sn(L2)2 | C22H26Br2N8S4Sn | White | 260 | 10.54 | 32.42 (32.65) | 3.12 (3.24) | 13.58 (13.85) | 15.81 (15.85) | 14.65 (14.67) |
| HL3(BTIMT) | C10H11BrN4S2 | Light Brown | 174 | — | 36.44 (36.26) | 3.36 (3.35) | 16.96 (16.91) | 19.38 (19.36) | — |
| Me2SiCl(L3) | C12H16BrClN4S2Si | Pale Yellow | 244 | 15.88 | 34.06 (34.00) | 3.70 (3.80) | 13.44 (13.22) | 15.18 (15.13) | 6.67 (6.63) |
| Me2Si(L3)2 | C22H26Br2N8S4Si | Light Yellow | 252 | 11.47 | 36.44 (36.77) | 3.46 (3.65) | 15.62 (15.59) | 17.79 (17.85) | 3.89 (3.91) |
| Me2SnCl(L3) | C12H16BrClN4S2Sn | Dark Brown | 262 | 13.49 | 28.12 (28.01) | 3.42 (3.13) | 10.10 (10.08) | 12.42 (12.47) | 23.10 (23.07) |
| Me2Sn(L3)2 | C22H26Br2N8S4Sn | Light Yellow | 272 | 10.21 | 32.42 (32.65) | 3.27 (3.24) | 13.72 (13.85) | 15.91 (15.85) | 14.69 (14.67) |
IR-spectroscopic data (cm−1) of the ligands and their metal complexes.
| Compound |
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| HL1(BTMMT) | 3117 | 1597 | 1173 | 2754 | — | — | — |
| Me2SiCl(L1) | — | 1628 | 717 | — | 453 | 572 | 418 |
| Me2Si(L1)2 | — | 1628 | 710 | — | 458 | 576 | — |
| Me2SnCl(L1) | — | 1643 | 741 | — | 403 | 528 | 378 |
| Me2Sn(L1)2 | — | 1643 | 741 | — | 416 | 538 | — |
| HL2(BTMPT) | 3109 | 1589 | 1111 | 2754 | — | — | — |
| Me2SiCl(L2) | — | 1636 | 702 | — | 452 | 570 | 420 |
| Me2Si(L2)2 | — | 1697 | 741 | — | 446 | 582 | — |
| Me2SnCl(L2) | — | 1674 | 741 | — | 416 | 542 | 396 |
| Me2Sn(L2)2 | — | 1674 | 733 | — | 418 | 543 | — |
| HL3(BTIMT) | 3094 | 1582 | 1126 | 2777 | — | — | — |
| Me2SiCl(L3) | — | 1655 | 756 | — | 456 | 563 | 426 |
| Me2Si(L3)2 | — | 1659 | 741 | — | 452 | 578 | — |
| Me2SnCl(L3) | — | 1651 | 764 | — | 410 | 536 | 395 |
| Me2Sn(L3)2 | — | 1659 | 733 | — | 416 | 544 | — |
a = Ligands.
b = Complexes.
Figure 21H NMR spectrum of Schiff base (HL3).
Figure 31H NMR spectrum of Si (1 : 1) metal complex of ligand (HL3).
1HNMR chemical shifts of the ligands and their metal complexes.
| Compound | –CH=N | –SH | Aromatic-H | Triazole-CH3, –CH2–CH2–CH3, –CH(CH3) |
|---|---|---|---|---|
| HL1(BTMMT) | 11.70 (s) | 10.47 (s) | 7.30 (d, 1H, | 2.45 (s, 3H) |
| Me2SiCl(L1) | 9.64 (s) | — | 7.35 (d, 1H, | 2.42 (s, 3H) |
| Me2Si(L1)2 | 11.12 (s) | — | 7.42 (d, 2 H, | 2.19 (s, 6H) |
| Me2SnCl(L1) | 11.19 (s) | — | 7.26 (d,1H, | 2.22 (s, 3H) |
| Me2Sn(L1)2 | 11.15 (s) | — | 7.36 (d, 2H, | 2.10 (s, 6H) |
| HL2(BTMPT) | 10.91 (s) | 13.75 (s) | 7.31 (d, 1H, | 2.78 (t, 2H, |
| Me2SiCl(L2) | 10.41 (s) | — | 7.44 (d, 1H, | 2.64 (t, 2H, |
| Me2Si(L2)2 | 8.41 (s) | — | 7.43 (d, 2H, | 2.63 (t, 4H, |
| Me2SnCl(L2) | 8.49 (s) | — | 7.20 (d, 1H, | 2.62 (t, 2H, |
| Me2Sn(L2)2 | 8.87 (s) | — | 7.36 (d, 2H, | 2.68 (t, 4H, |
| HL3(BTIMT) | 10.63 (s) | 11.10 (s) | 7.31(d, 1H, | 3.29–3.20 (m, 1H); 1.36 (d, 6H, |
| Me2SiCl(L3) | 10.32 (s) | — | 7.51 (d, 1H, | 3.28–3.12 (m, 1H,); 1.25 (d, 6H, |
| Me2Si(L3)2 | 8.44 (s) | — | 7.10 (d, 2H, | 3.14–2.86 (m, 2H); 1.25 (d,12H, |
| Me2SnCl(L3) | 8.40 (s) | — | 7.12 (d, 1H, | 2.87–2.73 (m, 1 H); 1.17 (d, 6 H, |
| Me2Sn(L3)2 | 8.48 (s) | — | 7.10 (d, 2H, | 2.92–2.83 (m, 2H); 1.18 (d,12H, |
C13 NMR chemical shifts of the ligands and their metal complexes.
| Compound | C1 | C2 | C3 | C4 | C5 | C6 | C7 | C8 | C9 | C10 | M–CH3 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HL1(BTMMT) | 124.05 | 135.85 | 139.06 | 143.92 | 166.42 | 153.51 | 157.32 | 15.67 | — | — | — |
| Me2SiCl(L1) | 131.77 | 132.39 | 137.24 | 137.94 | 183.07 | 138.32 | 156.08 | 9.5 | — | — | 18.11 |
| Me2Si(L1)2 | 116.70 | 132.06 | 133.60 | 141.23 | 160.96 | 147.79 | 149.04 | 11.32 | — | — | 28.22 |
| Me2SnCl(L1) | 120.65 | 132.03 | 132.98 | 142.52 | 162.54 | 147.89 | 148.26 | 11.65 | — | — | 30.11 |
| Me2Sn(L1)2 | 116.03 | 131.94 | 132.82 | 141.82 | 161.23 | 147.33 | 147.58 | 11.37 | — | — | 32.11 |
| HL2(BTMPT) | 120.15 | 131.09 | 134.59 | 138.97 | 162.23 | 152.73 | 152.92 | 13.69 | 19.29 | 26.91 | — |
| Me2SiCl(L2) | 119.30 | 131.84 | 135.64 | 139.04 | 183.06 | 154.32 | 156.02 | 13.76 | 19.44 | 26.81 | 18.23 |
| Me2Si(L2)2 | 128.18 | 129.28 | 131.98 | 141.72 | 161.81 | 153.26 | 154.25 | 14.58 | 19.02 | 25.95 | 24.66 |
| Me2SnCl(L2) | 126.23 | 128.56 | 131.23 | 140.58 | 162.48 | 152.56 | 154.85 | 14.23 | 18.65 | 26.42 | 31.32 |
| Me2Sn(L2)2 | 124.26 | 130.45 | 132.05 | 141.62 | 161.98 | 153.26 | 154.26 | 14.42 | 18.87 | 26.86 | 32.00 |
| HL3(BTIMT) | 124.18 | 135.96 | 139.22 | 143.95 | 160.79 | 157.86 | 157.26 | 30.27 | 24.44 | 24.44 | — |
| Me2SiCl(L3) | 118.67 | 132.03 | 135.82 | 139.08 | 161.95 | 154.71 | 154.98 | 25.56 | 19.79 | 19.79 | 19.12 |
| Me2Si(L3)2 | 120.42 | 129.45 | 133.25 | 138.55 | 160.78 | 152.53 | 151.25 | 28.45 | 20.25 | 22.76 | 29.10 |
| Me2SnCl(L3) | 122.62 | 128.46 | 132.46 | 139.42 | 161.86 | 153.24 | 154.25 | 27.56 | 19.45 | 24.57 | 29.88 |
| Me2Sn(L3)2 | 124.56 | 130.54 | 135.03 | 141.21 | 162.46 | 154.48 | 153.24 | 28.89 | 21.22 | 26.43 | 31.89 |
Figure 429Si NMR spectrum of Si (1 : 1) metal complex of ligand (HL1).
In vitro antibacterial activity of the ligands and their metal complexes.
| Compounds | Zone of inhibition (mm)a | |||
|---|---|---|---|---|
|
|
|
|
| |
| HL1(BTMMT) | 16.2 | 15.6 | — | — |
| Me2SiCl(L1) | 21.6 | — | — | — |
| Me2Si(L1)2 | 20.3 | — | — | — |
| Me2SnCl(L1) | 24.6 | 22.6 | — | — |
| Me2Sn(L1)2 | — | 18.6 | — | — |
| HL2(BTMPT) | 18.8 | 18.6 | — | — |
| Me2SiCl(L2) | 23.6 | 21.3 | — | — |
| Me2Si(L2)2 | 17.3 | 15.2 | — | — |
| Me2SnCl(L2) | — | — | — | — |
| Me2Sn(L2)2 | 15.3 | 16.3 | — | — |
| HL3(BTIMT) | — | 15.9 | — | — |
| Me2SiCl(L3) | — | 20.2 | — | — |
| Me2Si(L3)2 | — | 16.2 | — | — |
| Me2SnCl(L3) | — | 16.8 | — | — |
| Me2Sn(L3)2 | — | 15.3 | — | — |
| Ciprofloxacin | 27.6 | 26 | — | — |
—: No activity.
aValues, including diameter of the well (8 mm), are means of three replicates.
Minimum inhibitory concentration (MIC) in μg/mL of the ligands and their metal complexes.
| Compound |
|
|
|---|---|---|
| HL1(BTMMT) | >128 | 128 |
| Me2SiCl(L1) | 64 | Nt |
| Me2Si(L1)2 | 64 | Nt |
| Me2SnCl(L1) | 28 | 54 |
| Me2Sn(L1)2 | Nt | 64 |
| HL2(BTMPT) | Nt | 128 |
| Me2SiCl(L2) | 28 | 58 |
| Me2Si(L2)2 | 128 | >128 |
| Me2SnCl(L2) | — | — |
| Me2Sn(L2)2 | 128 | 128 |
| HL3(BTIMT) | Nt | 128 |
| Me2SiCl(L3) | Nt | 128 |
| Me2Si(L3)2 | Nt | 128 |
| Me2SnCl(L3) | Nt | 128 |
| Me2Sn(L3)2 | Nt | 128 |
| Ciprofloxacin | 5 | 5 |
Nt: Not tested.
In vitro antifungal activity of the ligands and their metal complexes.
| Compound | Mycelial growth inhibition (%) | |
|---|---|---|
|
|
| |
| HL1(BTMMT) | 44.4 | 45.5 |
| Me2SiCl(L1) | 55.2 | 52.5 |
| Me2Si(L1)2 |
|
|
| Me2SnCl(L1) | 48.8 | 52.5 |
| Me2Sn(L1)2 | 44.4 | 50 |
| HL2(BTMPT) | 44.4 | 44.4 |
| Me2SiCl(L2) | 51.1 | 53.3 |
| Me2Si(L2)2 | 44.4 | 48.8 |
| Me2SnCl(L2) | 49.4 | 48.4 |
| Me2Sn(L2)2 | 44.4 | 48.8 |
| HL3(BTIMT) | 50 | 53.3 |
| Me2SiCl(L3) | 48.8 | 44.4 |
| Me2Si(L3)2 |
|
|
| Me2SnCl(L3) | 45 | 48.8 |
| Me2Sn(L3)2 | 50 | 51.1 |
| Fluconazole | 81.1 | 77.7 |
Figure 5Comparison of antifungal activity of compounds with commercial antibiotic.
Figure 6Proposed structures of the 1 : 1 and 1 : 2 complexes, where 1 : 1 complexes, coordination number = 5 are proposed to have trigonal bipyramidal and 1 : 2 complexes, coordination number = 6 are proposed to have octahedral geometries.